title: Successful management of predicted severe ovarian hyperstimulation syndrome with gonadotropin-releasing hormone agonist.
authors.affiliation: Department of Obstetrics and Gynecology School of Medicine, University of California, Los Angeles 90024.
authors.forename: T C
authors.initials: TC
authors.lastname: Wu
authors.forename: T J
authors.initials: TJ
authors.lastname: Gelety
authors.forename: M H
authors.initials: MH
authors.lastname: Jih
authors.forename: N
authors.initials: N
authors.lastname: Fournet
authors.forename: R
authors.initials: R
authors.lastname: Buyalos
mesh_terms: D000328:Adult; D003692:Delayed-Action Preparations; D004359:Drug Therapy, Combination; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use*; D016471:Ovarian Hyperstimulation Syndrome / Q000517:prevention & control*; D010062:Ovulation Induction / Q000009:adverse effects*; D017329:Triptorelin Pamoate / Q000031:analogs & derivatives*
chemical_list: D003692:Delayed-Action Preparations; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone; C019176:Tryptal; D016729:Leuprolide